ALI HEALTH (00241) rose more than 4% in early trading. As of press time, the stock was up 2.91% to HK$4.60, with a turnover of HK$78.76 million. On the news front, according to an announcement from ALI HEALTH, the company officially launched its medical AI "Hydrogen Ion" in Hangzhou on May 13. Simultaneously, it announced an exclusive content partnership between Hydrogen Ion and the British BMJ Group. This collaboration marks the beginning of ALI HEALTH's cooperation with top-tier international journals. Hydrogen Ion revealed that it is currently in discussions with several leading global publications for further partnerships. At the launch event, ALI HEALTH stated that Hydrogen Ion aims to create a more reliable medical AI assistant by excelling in three dimensions: "top-tier medical evidence," "evidence-based medicine," and "AI capabilities." It directly connects to the highest-quality evidence sources from domestic and international top journals, assisting Chinese doctors in addressing medical issues. It was introduced that under the exclusive content agreement between Hydrogen Ion and the BMJ Group, content and multimedia resources from the past ten years across BMJ's 70 medical journals will be exclusively licensed to "Hydrogen Ion." Hydrogen Ion thus becomes the BMJ Group's exclusive medical AI platform partner in China. Moving forward, Chinese doctors will be able to use Hydrogen Ion to directly access global top-tier medical literature, enabling evidence-based Q&A, full-text reading, and online translation to resolve medical questions in clinical and research settings.